The overarching goal of this clinical-translational study is to advance nursing science and the wound care field, by elucidating critical molecular pathways driving recalcitrant wounds, and correlating them with patient-centric outcome measures including pain and wound outcomes. Utilizing the resources of the Georgetown-Howard Center for Clinical and Translational Science and the J. Craig Venter Institute, the investigators will draw upon a multidisciplinary team to apply high-throughput genomic technologies and investigate the interplay between host immune and angiogenesis pathways, wound biofilm, patient reported pain and analgesic use in chronic wounds. To achieve these goals we specifically aim: 1.Toestablish host molecular signatures predictive of wound outcome. In a well phenotyped cohort of patients with healing and recalcitrant chronic wounds, we predict there will be differential expression of immune, eicosanoid signaling and angiogenic pathways. We will investigate this by: a. Identifying differentially expressed genes based on mRNA expression profiles between recalcitrant and healing chronic wounds. b. Validating mRNA expression profiles using quantitative reverse transcriptase-polymerase chain reaction and immunohistochemistry. 2. To establish the bacterial profile, virulence and pathogenicity markers and correlate them with host immune response pathways and wound outcome. We predict that recalcitrant chronic wounds will exhibit different wound-bed bacterial profiles, virulence or pathogenicity markers, and that these profiles will correlate with host immune response signatures and pain. To investigate this hypothesis we will: a. Use bacterial 16S ribosomal RNA gene profiles to compare wound biofilm bacterial diversity between healing and recalcitrant chronic wounds. b. Correlate the microbiome profile with host immune response, pain, co-morbidities and outcome. 3. To correlate wound-related pain with pathways of eicosanoid signalling, cumulative analgesic requirements and wound outcome. We postulate that recalcitrant wounds will exhibit up regulation of eicosanoid signalling pathways and that this will correlate with wound-related pain scores, analgesic use and outcome. We propose: a. Correlating patient-reported pain scores with eicosanoid signalling pathways. b. Investigating possible relationships between exposure to different classes of analgesics, cumulative analgesic doses and wound outcome.
Chronic wounds are major public health problem affecting 1% of the US population and costing approximately $25 billion per year. Recent studies suggest that mortality in patients with chronic wounds approaches that seen in some malignancies, and there is an urgent need to identify effective therapies that both improve ultimate wound outcome, and alleviate patient symptoms and suffering. The proposed research will focus on both of these aims, by elucidating critical molecular pathways driving recalcitrant wounds, facilitating translation of these findings to identify clinically predictive biomarkers, and identiying therapeutic targets to improve outcomes and wound related pain.
|Mulani, Shaunak; McNish, Sean; Jones, Derek et al. (2018) Prevalence of antinuclear antibodies in hidradenitis suppurativa. Int J Rheum Dis 21:1018-1022|
|Shanmugam, Victoria K; Mulani, Shaunak; McNish, Sean et al. (2018) Longitudinal observational study of hidradenitis suppurativa: impact of surgical intervention with adjunctive biologic therapy. Int J Dermatol 57:62-69|
|Boortalary, Tina; Misra, Kanchan; McNish, Sean et al. (2018) Prevalence of positive QuantiFERON gold in-tube testing in hidradenitis suppurativa. J Dermatolog Treat 29:637-640|
|Gourh, Pravitt; Remmers, Elaine F; Boyden, Steven E et al. (2018) Brief Report: Whole-Exome Sequencing to Identify Rare Variants and Gene Networks That Increase Susceptibility to Scleroderma in African Americans. Arthritis Rheumatol 70:1654-1660|
|Jones, Derek; Banerjee, Anirban; Berger, Peter Z et al. (2018) Inherent differences in keratinocyte function in hidradenitis suppurativa: Evidence for the role of IL-22 in disease pathogenesis. Immunol Invest 47:57-70|
|Shanmugam, Victoria K; Angra, Divya; Rahimi, Hamza et al. (2017) Vasculitic and autoimmune wounds. J Vasc Surg Venous Lymphat Disord 5:280-292|
|Patel, Falin B; Couch, Kara S; McNish, Sean et al. (2017) A 66-Year-Old Woman With Hemoptysis. Arthritis Care Res (Hoboken) 69:439-448|
|Banerjee, Anirban; McNish, Sean; Shanmugam, Victoria K (2017) Interferon-gamma (IFN-?) is Elevated in Wound Exudate from Hidradenitis Suppurativa. Immunol Invest 46:149-158|
|Shanmugam, Victoria K; Couch, Kara S; McNish, Sean et al. (2017) Relationship between opioid treatment and rate of healing in chronic wounds. Wound Repair Regen 25:120-130|
|Shanmugam, Victoria K (2016) Vasculitic Diseases and Prothrombotic States Contributing to Delayed Healing In Chronic Wounds. Curr Dermatol Rep 5:270-277|
Showing the most recent 10 out of 19 publications